Lawsuit Pending for Investors in Outset Medical, Inc. (NASDAQ:OM) Shares – Contact Shareholders Foundation

Investors in Outset Medical, Inc. (NASDAQ:OM) shares are facing a pending lawsuit over alleged securities laws violations. The lawsuit, filed by an investor on August 29, 2024, claims that Outset Medical failed to disclose important information to investors regarding the marketing of their Tablo products for continuous renal replacement therapy, which is not an approved indication by the FDA.

The plaintiff also alleges that Outset Medical was likely to submit an additional application for FDA approval, potentially leading to a halt in sales of the Tablo products. Additionally, the lawsuit claims that the company lacked the necessary sales team and processes to support the growth of Tablo sales, impacting revenue growth.

Investors who purchased shares of Outset Medical, Inc. (NASDAQ: OM) are encouraged to contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554 to learn more about their options in light of this pending lawsuit.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and settlement claim filing service that provides information on shareholder issues, securities class actions, settlements, and other legal news related to the stock market. It is important for investors to stay informed and seek guidance in situations like these to protect their investments.